Canadian Cancer Society Emerging Scholar
Max Rady College of Medicine
Room 400 - 727 McDermot Avenue
University of Manitoba
Winnipeg, Manitoba R3E 3P5
Dr. Tanveer Sharif’s current research is focused on identifying and characterizing new metabolism-based precision medicine therapeutic strategies for treating aggressive brain tumors. His work focuses on the two most common types of brain cancers in children and adults, medulloblastoma (MB) and glioblastoma (GBM). Using relevant cell and animal models as well as patient-derived brain tumor samples, Dr. Sharif’s research takes an in-depth approach to investigate the molecular mechanisms that mediate metabolic vulnerabilities and tumor heterogeneity to identify new therapeutic targets to improve patient responses and outcomes.
Dr. Tanveer Sharif is a pharmacist turned researcher, he received his BSc in Pharmacy and MSc in Pharmacology. Dr. Sharif completed his PhD at the University of Strasbourg in France before moving to Canada in 2013 to pursue his postdoctoral fellowship at Dalhousie University, where he trained under the supervision of Dr. Patrick W.K. Lee prior to his retirement.
At Dalhousie, Dr. Sharif studied the role of tumor suppressors and metabolism in embryonal carcinoma stem cells and patient-derived brain tumor-initiating cells. In 2019, Dr. Sharif joined UM as a principal investigator to lead a new tumor suppressor biology, autophagy and Mmtabolism program in the department of pathology.
Visit Tanveer Sharif's ORCID profile for a complete listing.